The FDA has approved Apidra SoloSTAR (insulin glulisine[rDNA origin] injection, from sanofi-aventis), a prefilled disposable pencontaining Apidra. Apidra SoloSTAR makes administration of insulin ...
BRIDGEWATER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) SoloSTAR(R ...
Feb. 27 -- THURSDAY, Feb. 26 (HealthDay News) -- Sanofi-Aventis's Apidra (insulin glulisine) Solostar injection pen has been approved to treat diabetes, the company said Thursday in a news release.
(Reuters Health) - A warning for people who use insulin pens: Not shaking your NPH insulin pen before injecting can result in wide variations in your insulin level and blood sugar control, researchers ...
French pharmaceutical manufacturer Sanofi recently notified doctors that they will soon face a shortage of an insulin pen product. The shortage is caused by a "technical incident" at a manufacturing ...
This new prefilled insulin injection pen has a unique spring-loaded mechanism. The pen has a no push-button extension at any dose and a low injection force, designed to make self-injecting easier for ...
Novo Nordisk has announced that two of its smart connected insulin pens, NovoPen 6 and NovoPen Echo Plus will be available within the NHS. NovoPen 6 and NovoPen Echo Plus are novel insulin pens that ...
Apidra SoloSTAR (insulin glulisine [rDNA origin] injection, from sanofi-aventis), a prefilled disposable pen containing Apidra, is now available. Apidra SoloSTAR makes administration of insulin more ...
March 3, 2009 — On February 26, sanofi-aventis announced that a prefilled disposable pen containing insulin glulisine (Apidra SoloSTAR) was approved by the US Food and Drug Administration (FDA). This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback